nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—ABCB1—colon cancer	0.208	1	CbGaD
Vincristine—ABCC3—Fluorouracil—colon cancer	0.0744	0.136	CbGbCtD
Vincristine—SLC22A3—Irinotecan—colon cancer	0.0729	0.133	CbGbCtD
Vincristine—ABCC10—Methotrexate—colon cancer	0.0653	0.119	CbGbCtD
Vincristine—ABCC1—Irinotecan—colon cancer	0.0476	0.0867	CbGbCtD
Vincristine—ABCC3—Methotrexate—colon cancer	0.041	0.0748	CbGbCtD
Vincristine—ABCC2—Irinotecan—colon cancer	0.0352	0.0642	CbGbCtD
Vincristine—ABCG2—Irinotecan—colon cancer	0.0319	0.0581	CbGbCtD
Vincristine—ABCG2—Fluorouracil—colon cancer	0.0306	0.0557	CbGbCtD
Vincristine—ABCC1—Methotrexate—colon cancer	0.0252	0.0459	CbGbCtD
Vincristine—CYP3A7—Irinotecan—colon cancer	0.0235	0.0429	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0235	0.0429	CbGbCtD
Vincristine—ABCC2—Methotrexate—colon cancer	0.0187	0.034	CbGbCtD
Vincristine—CYP3A5—Irinotecan—colon cancer	0.0177	0.0322	CbGbCtD
Vincristine—ABCG2—Methotrexate—colon cancer	0.0169	0.0307	CbGbCtD
Vincristine—ABCB1—Irinotecan—colon cancer	0.0115	0.0209	CbGbCtD
Vincristine—ABCB11—bile—colon cancer	0.00867	0.111	CbGeAlD
Vincristine—CYP3A4—Irinotecan—colon cancer	0.00688	0.0125	CbGbCtD
Vincristine—ABCB1—Methotrexate—colon cancer	0.00608	0.0111	CbGbCtD
Vincristine—ABCC2—bile—colon cancer	0.00441	0.0562	CbGeAlD
Vincristine—Cranial nerve paralysis—Methotrexate—colon cancer	0.00316	0.0314	CcSEcCtD
Vincristine—Tumour lysis syndrome—Irinotecan—colon cancer	0.00263	0.0261	CcSEcCtD
Vincristine—Septic shock—Fluorouracil—colon cancer	0.00232	0.023	CcSEcCtD
Vincristine—Cerebral infarction—Irinotecan—colon cancer	0.00224	0.0223	CcSEcCtD
Vincristine—Facial paralysis—Capecitabine—colon cancer	0.00154	0.0153	CcSEcCtD
Vincristine—ABCC3—gall bladder—colon cancer	0.00153	0.0195	CbGeAlD
Vincristine—Pain in jaw—Capecitabine—colon cancer	0.0015	0.0149	CcSEcCtD
Vincristine—Myelosuppression—Fluorouracil—colon cancer	0.00149	0.0148	CcSEcCtD
Vincristine—Voacamine—ABCB1—colon cancer	0.00145	0.549	CrCbGaD
Vincristine—Leukaemia—Methotrexate—colon cancer	0.00135	0.0134	CcSEcCtD
Vincristine—Tumour lysis syndrome—Methotrexate—colon cancer	0.00131	0.013	CcSEcCtD
Vincristine—TUBB3—lymphoid tissue—colon cancer	0.00127	0.0162	CbGeAlD
Vincristine—Neurotoxicity—Capecitabine—colon cancer	0.00126	0.0125	CcSEcCtD
Vincristine—TUBB3—digestive system—colon cancer	0.00125	0.016	CbGeAlD
Vincristine—TUBA4A—epithelium—colon cancer	0.00125	0.016	CbGeAlD
Vincristine—TUBB4A—embryo—colon cancer	0.00123	0.0157	CbGeAlD
Vincristine—Febrile neutropenia—Irinotecan—colon cancer	0.00121	0.0121	CcSEcCtD
Vincristine—TUBA4A—smooth muscle tissue—colon cancer	0.00121	0.0154	CbGeAlD
Vincristine—VIIth nerve paralysis—Capecitabine—colon cancer	0.00119	0.0118	CcSEcCtD
Vincristine—Febrile neutropenia—Fluorouracil—colon cancer	0.00116	0.0115	CcSEcCtD
Vincristine—TUBA4A—renal system—colon cancer	0.00116	0.0148	CbGeAlD
Vincristine—RALBP1—smooth muscle tissue—colon cancer	0.00114	0.0145	CbGeAlD
Vincristine—TUBB1—bone marrow—colon cancer	0.00113	0.0144	CbGeAlD
Vincristine—Ileus paralytic—Capecitabine—colon cancer	0.00113	0.0112	CcSEcCtD
Vincristine—RALBP1—renal system—colon cancer	0.00109	0.014	CbGeAlD
Vincristine—Abdominal cramps—Irinotecan—colon cancer	0.00108	0.0107	CcSEcCtD
Vincristine—Intestinal obstruction—Irinotecan—colon cancer	0.00107	0.0106	CcSEcCtD
Vincristine—Altered state of consciousness—Capecitabine—colon cancer	0.00106	0.0105	CcSEcCtD
Vincristine—Ileus—Irinotecan—colon cancer	0.00103	0.0102	CcSEcCtD
Vincristine—Paresis—Methotrexate—colon cancer	0.000997	0.00991	CcSEcCtD
Vincristine—Nystagmus—Fluorouracil—colon cancer	0.000979	0.00973	CcSEcCtD
Vincristine—TUBA4A—lymphoid tissue—colon cancer	0.000964	0.0123	CbGeAlD
Vincristine—TUBB4B—embryo—colon cancer	0.000959	0.0122	CbGeAlD
Vincristine—TUBA4A—digestive system—colon cancer	0.000952	0.0121	CbGeAlD
Vincristine—ABCB11—digestive system—colon cancer	0.000947	0.0121	CbGeAlD
Vincristine—Neurotoxicity—Methotrexate—colon cancer	0.000938	0.00932	CcSEcCtD
Vincristine—TUBB4A—renal system—colon cancer	0.00093	0.0119	CbGeAlD
Vincristine—TUBB6—epithelium—colon cancer	0.0009	0.0115	CbGeAlD
Vincristine—TUBB2B—renal system—colon cancer	0.000899	0.0115	CbGeAlD
Vincristine—RALBP1—digestive system—colon cancer	0.000897	0.0114	CbGeAlD
Vincristine—TUBB—smooth muscle tissue—colon cancer	0.000884	0.0113	CbGeAlD
Vincristine—TUBB2A—smooth muscle tissue—colon cancer	0.000879	0.0112	CbGeAlD
Vincristine—TUBA4A—bone marrow—colon cancer	0.000878	0.0112	CbGeAlD
Vincristine—TUBB6—smooth muscle tissue—colon cancer	0.000867	0.0111	CbGeAlD
Vincristine—Numbness—Fluorouracil—colon cancer	0.000844	0.00838	CcSEcCtD
Vincristine—TUBA4A—vagina—colon cancer	0.000841	0.0107	CbGeAlD
Vincristine—Extravasation—Irinotecan—colon cancer	0.000837	0.00832	CcSEcCtD
Vincristine—TUBB6—renal system—colon cancer	0.000835	0.0106	CbGeAlD
Vincristine—RALBP1—bone marrow—colon cancer	0.000827	0.0106	CbGeAlD
Vincristine—SLC22A3—embryo—colon cancer	0.000826	0.0105	CbGeAlD
Vincristine—Myoclonus—Capecitabine—colon cancer	0.000812	0.00807	CcSEcCtD
Vincristine—Febrile neutropenia—Capecitabine—colon cancer	0.000812	0.00807	CcSEcCtD
Vincristine—Sensory loss—Fluorouracil—colon cancer	0.000807	0.00802	CcSEcCtD
Vincristine—Extravasation—Fluorouracil—colon cancer	0.000802	0.00796	CcSEcCtD
Vincristine—RALBP1—vagina—colon cancer	0.000793	0.0101	CbGeAlD
Vincristine—TUBB4A—lymphoid tissue—colon cancer	0.000773	0.00985	CbGeAlD
Vincristine—Respiratory distress—Capecitabine—colon cancer	0.000769	0.00764	CcSEcCtD
Vincristine—TUBB4A—digestive system—colon cancer	0.000763	0.00973	CbGeAlD
Vincristine—TUBB4B—smooth muscle tissue—colon cancer	0.000754	0.00962	CbGeAlD
Vincristine—Gait disturbance—Irinotecan—colon cancer	0.000748	0.00743	CcSEcCtD
Vincristine—TUBB2B—digestive system—colon cancer	0.000738	0.00941	CbGeAlD
Vincristine—ABCC3—renal system—colon cancer	0.000735	0.00937	CbGeAlD
Vincristine—ABCC10—renal system—colon cancer	0.000731	0.00932	CbGeAlD
Vincristine—TUBB4B—renal system—colon cancer	0.000726	0.00926	CbGeAlD
Vincristine—Bone marrow depression—Capecitabine—colon cancer	0.000724	0.00719	CcSEcCtD
Vincristine—Intestinal obstruction—Capecitabine—colon cancer	0.000717	0.00712	CcSEcCtD
Vincristine—TUBA4A—liver—colon cancer	0.000709	0.00905	CbGeAlD
Vincristine—ABCB11—liver—colon cancer	0.000705	0.009	CbGeAlD
Vincristine—TUBB2A—digestive system—colon cancer	0.000694	0.00886	CbGeAlD
Vincristine—TUBB6—lymphoid tissue—colon cancer	0.000693	0.00884	CbGeAlD
Vincristine—Ileus—Capecitabine—colon cancer	0.000691	0.00686	CcSEcCtD
Vincristine—CYP3A7—liver—colon cancer	0.00069	0.0088	CbGeAlD
Vincristine—TUBB6—digestive system—colon cancer	0.000685	0.00873	CbGeAlD
Vincristine—Azotaemia—Methotrexate—colon cancer	0.000683	0.00678	CcSEcCtD
Vincristine—Vinorelbine—ABCB1—colon cancer	0.00067	0.254	CrCbGaD
Vincristine—RALBP1—liver—colon cancer	0.000669	0.00853	CbGeAlD
Vincristine—TUBB2B—vagina—colon cancer	0.000651	0.00831	CbGeAlD
Vincristine—SLC22A3—smooth muscle tissue—colon cancer	0.00065	0.00829	CbGeAlD
Vincristine—TUBB—bone marrow—colon cancer	0.000643	0.00821	CbGeAlD
Vincristine—TUBB2A—bone marrow—colon cancer	0.00064	0.00816	CbGeAlD
Vincristine—Coma—Fluorouracil—colon cancer	0.000639	0.00635	CcSEcCtD
Vincristine—TUBB6—bone marrow—colon cancer	0.000631	0.00805	CbGeAlD
Vincristine—SLC22A3—renal system—colon cancer	0.000625	0.00798	CbGeAlD
Vincristine—TUBB—vagina—colon cancer	0.000616	0.00786	CbGeAlD
Vincristine—TUBB2A—vagina—colon cancer	0.000613	0.00782	CbGeAlD
Vincristine—ABCC10—lymphoid tissue—colon cancer	0.000607	0.00774	CbGeAlD
Vincristine—Febrile neutropenia—Methotrexate—colon cancer	0.000605	0.00601	CcSEcCtD
Vincristine—TUBB6—vagina—colon cancer	0.000605	0.00771	CbGeAlD
Vincristine—TUBB4B—lymphoid tissue—colon cancer	0.000603	0.00769	CbGeAlD
Vincristine—ABCC3—digestive system—colon cancer	0.000602	0.00769	CbGeAlD
Vincristine—ABCC10—digestive system—colon cancer	0.0006	0.00765	CbGeAlD
Vincristine—TUBB4B—digestive system—colon cancer	0.000595	0.00759	CbGeAlD
Vincristine—ABCC2—renal system—colon cancer	0.000587	0.00749	CbGeAlD
Vincristine—CYP3A7-CYP3A51P—liver—colon cancer	0.000587	0.00748	CbGeAlD
Vincristine—TUBB4A—liver—colon cancer	0.000569	0.00725	CbGeAlD
Vincristine—ABCC10—bone marrow—colon cancer	0.000553	0.00705	CbGeAlD
Vincristine—TUBB4B—bone marrow—colon cancer	0.000549	0.007	CbGeAlD
Vincristine—TUBA4A—lymph node—colon cancer	0.000544	0.00694	CbGeAlD
Vincristine—Bone marrow depression—Methotrexate—colon cancer	0.000539	0.00535	CcSEcCtD
Vincristine—Hyponatraemia—Irinotecan—colon cancer	0.000532	0.00529	CcSEcCtD
Vincristine—ABCC10—vagina—colon cancer	0.000529	0.00675	CbGeAlD
Vincristine—TUBB4B—vagina—colon cancer	0.000526	0.00671	CbGeAlD
Vincristine—Paralysis—Methotrexate—colon cancer	0.000524	0.0052	CcSEcCtD
Vincristine—TUBB—liver—colon cancer	0.00052	0.00663	CbGeAlD
Vincristine—TUBB2A—liver—colon cancer	0.000517	0.0066	CbGeAlD
Vincristine—Vinblastine—ABCB1—colon cancer	0.000516	0.196	CrCbGaD
Vincristine—RALBP1—lymph node—colon cancer	0.000513	0.00654	CbGeAlD
Vincristine—Bone pain—Capecitabine—colon cancer	0.00051	0.00507	CcSEcCtD
Vincristine—TUBB6—liver—colon cancer	0.00051	0.00651	CbGeAlD
Vincristine—Cardiac arrest—Irinotecan—colon cancer	0.000504	0.00501	CcSEcCtD
Vincristine—Gait disturbance—Capecitabine—colon cancer	0.000501	0.00497	CcSEcCtD
Vincristine—Dehydration—Irinotecan—colon cancer	0.000493	0.0049	CcSEcCtD
Vincristine—Cardiac arrest—Fluorouracil—colon cancer	0.000483	0.0048	CcSEcCtD
Vincristine—ABCC2—digestive system—colon cancer	0.000481	0.00614	CbGeAlD
Vincristine—Ataxia—Fluorouracil—colon cancer	0.000477	0.00474	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000477	0.00474	CcSEcCtD
Vincristine—ABCB1—blood vessel—colon cancer	0.000467	0.00596	CbGeAlD
Vincristine—Neuropathy—Capecitabine—colon cancer	0.000459	0.00456	CcSEcCtD
Vincristine—SLC22A3—vagina—colon cancer	0.000453	0.00578	CbGeAlD
Vincristine—ABCC3—liver—colon cancer	0.000449	0.00573	CbGeAlD
Vincristine—Muscular weakness—Fluorouracil—colon cancer	0.000448	0.00445	CcSEcCtD
Vincristine—ABCC10—liver—colon cancer	0.000447	0.0057	CbGeAlD
Vincristine—TUBB4B—liver—colon cancer	0.000443	0.00566	CbGeAlD
Vincristine—Mouth ulceration—Capecitabine—colon cancer	0.000442	0.00439	CcSEcCtD
Vincristine—Urine output increased—Capecitabine—colon cancer	0.000442	0.00439	CcSEcCtD
Vincristine—TUBB4A—lymph node—colon cancer	0.000436	0.00556	CbGeAlD
Vincristine—Neutropenia—Irinotecan—colon cancer	0.000428	0.00426	CcSEcCtD
Vincristine—TUBB2B—lymph node—colon cancer	0.000421	0.00537	CbGeAlD
Vincristine—Extravasation—Methotrexate—colon cancer	0.000417	0.00414	CcSEcCtD
Vincristine—Pancytopenia—Fluorouracil—colon cancer	0.000417	0.00414	CcSEcCtD
Vincristine—Weight decreased—Irinotecan—colon cancer	0.000415	0.00412	CcSEcCtD
Vincristine—Pneumonia—Irinotecan—colon cancer	0.000411	0.00408	CcSEcCtD
Vincristine—Polyuria—Capecitabine—colon cancer	0.000404	0.00401	CcSEcCtD
Vincristine—Acute coronary syndrome—Irinotecan—colon cancer	0.000403	0.004	CcSEcCtD
Vincristine—Photosensitivity reaction—Fluorouracil—colon cancer	0.000401	0.00398	CcSEcCtD
Vincristine—Myocardial infarction—Irinotecan—colon cancer	0.0004	0.00398	CcSEcCtD
Vincristine—TUBB—lymph node—colon cancer	0.000399	0.00509	CbGeAlD
Vincristine—Stomatitis—Irinotecan—colon cancer	0.000398	0.00396	CcSEcCtD
Vincristine—CYP3A5—renal system—colon cancer	0.000397	0.00507	CbGeAlD
Vincristine—Deafness—Capecitabine—colon cancer	0.000397	0.00394	CcSEcCtD
Vincristine—TUBB2A—lymph node—colon cancer	0.000397	0.00506	CbGeAlD
Vincristine—Hepatic failure—Capecitabine—colon cancer	0.000395	0.00392	CcSEcCtD
Vincristine—Pneumonia—Fluorouracil—colon cancer	0.000394	0.00391	CcSEcCtD
Vincristine—Hyperuricaemia—Methotrexate—colon cancer	0.000392	0.0039	CcSEcCtD
Vincristine—Sweating—Irinotecan—colon cancer	0.000392	0.00389	CcSEcCtD
Vincristine—TUBB6—lymph node—colon cancer	0.000391	0.00499	CbGeAlD
Vincristine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000386	0.00383	CcSEcCtD
Vincristine—Neuropathy peripheral—Fluorouracil—colon cancer	0.000384	0.00381	CcSEcCtD
Vincristine—Myocardial infarction—Fluorouracil—colon cancer	0.000384	0.00381	CcSEcCtD
Vincristine—SLC22A3—liver—colon cancer	0.000382	0.00487	CbGeAlD
Vincristine—Stomatitis—Fluorouracil—colon cancer	0.000381	0.00379	CcSEcCtD
Vincristine—ABCC1—vagina—colon cancer	0.000374	0.00478	CbGeAlD
Vincristine—Blood uric acid increased—Methotrexate—colon cancer	0.000371	0.00368	CcSEcCtD
Vincristine—Respiratory failure—Methotrexate—colon cancer	0.000371	0.00368	CcSEcCtD
Vincristine—Connective tissue disorder—Irinotecan—colon cancer	0.00036	0.00358	CcSEcCtD
Vincristine—ABCC2—liver—colon cancer	0.000359	0.00457	CbGeAlD
Vincristine—Hyponatraemia—Capecitabine—colon cancer	0.000356	0.00354	CcSEcCtD
Vincristine—Pain in extremity—Capecitabine—colon cancer	0.000355	0.00352	CcSEcCtD
Vincristine—Hypoaesthesia—Fluorouracil—colon cancer	0.000349	0.00347	CcSEcCtD
Vincristine—ABCC3—lymph node—colon cancer	0.000344	0.00439	CbGeAlD
Vincristine—ABCC10—lymph node—colon cancer	0.000342	0.00437	CbGeAlD
Vincristine—Cardiac disorder—Irinotecan—colon cancer	0.00034	0.00338	CcSEcCtD
Vincristine—TUBB4B—lymph node—colon cancer	0.00034	0.00434	CbGeAlD
Vincristine—Cardiac arrest—Capecitabine—colon cancer	0.000337	0.00335	CcSEcCtD
Vincristine—Urinary retention—Capecitabine—colon cancer	0.000337	0.00335	CcSEcCtD
Vincristine—Ataxia—Capecitabine—colon cancer	0.000334	0.00331	CcSEcCtD
Vincristine—Angiopathy—Irinotecan—colon cancer	0.000333	0.00331	CcSEcCtD
Vincristine—Coma—Methotrexate—colon cancer	0.000332	0.0033	CcSEcCtD
Vincristine—Mediastinal disorder—Irinotecan—colon cancer	0.000331	0.00328	CcSEcCtD
Vincristine—Dehydration—Capecitabine—colon cancer	0.00033	0.00328	CcSEcCtD
Vincristine—Mouth ulceration—Methotrexate—colon cancer	0.000329	0.00327	CcSEcCtD
Vincristine—Urine output increased—Methotrexate—colon cancer	0.000329	0.00327	CcSEcCtD
Vincristine—CYP3A5—digestive system—colon cancer	0.000326	0.00416	CbGeAlD
Vincristine—Alopecia—Irinotecan—colon cancer	0.000324	0.00322	CcSEcCtD
Vincristine—ABCG2—bone marrow—colon cancer	0.000324	0.00413	CbGeAlD
Vincristine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00032	0.00317	CcSEcCtD
Vincristine—ABCC1—liver—colon cancer	0.000316	0.00403	CbGeAlD
Vincristine—Muscular weakness—Capecitabine—colon cancer	0.000313	0.00311	CcSEcCtD
Vincristine—Alopecia—Fluorouracil—colon cancer	0.00031	0.00308	CcSEcCtD
Vincristine—ABCG2—vagina—colon cancer	0.00031	0.00395	CbGeAlD
Vincristine—Back pain—Irinotecan—colon cancer	0.000309	0.00307	CcSEcCtD
Vincristine—Polyuria—Methotrexate—colon cancer	0.000301	0.00299	CcSEcCtD
Vincristine—CYP3A4—renal system—colon cancer	0.000298	0.0038	CbGeAlD
Vincristine—Anaemia—Irinotecan—colon cancer	0.000295	0.00293	CcSEcCtD
Vincristine—Hepatic failure—Methotrexate—colon cancer	0.000294	0.00292	CcSEcCtD
Vincristine—SLC22A3—lymph node—colon cancer	0.000293	0.00374	CbGeAlD
Vincristine—Pancytopenia—Capecitabine—colon cancer	0.000291	0.00289	CcSEcCtD
Vincristine—CYP3A5—vagina—colon cancer	0.000288	0.00367	CbGeAlD
Vincristine—Vertigo—Irinotecan—colon cancer	0.000287	0.00285	CcSEcCtD
Vincristine—Neutropenia—Capecitabine—colon cancer	0.000287	0.00285	CcSEcCtD
Vincristine—Dysuria—Capecitabine—colon cancer	0.000287	0.00285	CcSEcCtD
Vincristine—Leukopenia—Irinotecan—colon cancer	0.000286	0.00284	CcSEcCtD
Vincristine—Anaemia—Fluorouracil—colon cancer	0.000283	0.00281	CcSEcCtD
Vincristine—Photosensitivity reaction—Capecitabine—colon cancer	0.00028	0.00278	CcSEcCtD
Vincristine—ABCB1—embryo—colon cancer	0.000279	0.00356	CbGeAlD
Vincristine—Weight decreased—Capecitabine—colon cancer	0.000277	0.00276	CcSEcCtD
Vincristine—Hypertension—Irinotecan—colon cancer	0.000276	0.00274	CcSEcCtD
Vincristine—Pneumonia—Capecitabine—colon cancer	0.000275	0.00273	CcSEcCtD
Vincristine—ABCC2—lymph node—colon cancer	0.000275	0.00351	CbGeAlD
Vincristine—Leukopenia—Fluorouracil—colon cancer	0.000274	0.00272	CcSEcCtD
Vincristine—Depression—Capecitabine—colon cancer	0.000273	0.00271	CcSEcCtD
Vincristine—Acute coronary syndrome—Capecitabine—colon cancer	0.00027	0.00268	CcSEcCtD
Vincristine—Myocardial infarction—Capecitabine—colon cancer	0.000268	0.00266	CcSEcCtD
Vincristine—Neuropathy peripheral—Capecitabine—colon cancer	0.000268	0.00266	CcSEcCtD
Vincristine—Stomatitis—Capecitabine—colon cancer	0.000267	0.00265	CcSEcCtD
Vincristine—Convulsion—Fluorouracil—colon cancer	0.000265	0.00263	CcSEcCtD
Vincristine—ABCG2—liver—colon cancer	0.000262	0.00334	CbGeAlD
Vincristine—Oedema—Irinotecan—colon cancer	0.000261	0.00259	CcSEcCtD
Vincristine—Anaphylactic shock—Irinotecan—colon cancer	0.000261	0.00259	CcSEcCtD
Vincristine—Myalgia—Fluorouracil—colon cancer	0.00026	0.00259	CcSEcCtD
Vincristine—Infection—Irinotecan—colon cancer	0.000259	0.00257	CcSEcCtD
Vincristine—Nervous system disorder—Irinotecan—colon cancer	0.000256	0.00254	CcSEcCtD
Vincristine—Thrombocytopenia—Irinotecan—colon cancer	0.000255	0.00253	CcSEcCtD
Vincristine—Hyperhidrosis—Irinotecan—colon cancer	0.000252	0.0025	CcSEcCtD
Vincristine—Anaphylactic shock—Fluorouracil—colon cancer	0.00025	0.00248	CcSEcCtD
Vincristine—Oedema—Fluorouracil—colon cancer	0.00025	0.00248	CcSEcCtD
Vincristine—Anorexia—Irinotecan—colon cancer	0.000248	0.00247	CcSEcCtD
Vincristine—Ataxia—Methotrexate—colon cancer	0.000248	0.00247	CcSEcCtD
Vincristine—Infection—Fluorouracil—colon cancer	0.000248	0.00246	CcSEcCtD
Vincristine—Nervous system disorder—Fluorouracil—colon cancer	0.000245	0.00243	CcSEcCtD
Vincristine—CYP3A4—digestive system—colon cancer	0.000245	0.00312	CbGeAlD
Vincristine—Thrombocytopenia—Fluorouracil—colon cancer	0.000244	0.00243	CcSEcCtD
Vincristine—Hypoaesthesia—Capecitabine—colon cancer	0.000244	0.00243	CcSEcCtD
Vincristine—Hypotension—Irinotecan—colon cancer	0.000243	0.00242	CcSEcCtD
Vincristine—CYP3A5—liver—colon cancer	0.000243	0.0031	CbGeAlD
Vincristine—Urinary tract disorder—Capecitabine—colon cancer	0.000242	0.00241	CcSEcCtD
Vincristine—ABCC1—lymph node—colon cancer	0.000242	0.00309	CbGeAlD
Vincristine—Connective tissue disorder—Capecitabine—colon cancer	0.000241	0.0024	CcSEcCtD
Vincristine—Urethral disorder—Capecitabine—colon cancer	0.000241	0.00239	CcSEcCtD
Vincristine—Anorexia—Fluorouracil—colon cancer	0.000238	0.00236	CcSEcCtD
Vincristine—Insomnia—Irinotecan—colon cancer	0.000236	0.00234	CcSEcCtD
Vincristine—Paraesthesia—Irinotecan—colon cancer	0.000234	0.00232	CcSEcCtD
Vincristine—Hypotension—Fluorouracil—colon cancer	0.000233	0.00232	CcSEcCtD
Vincristine—Cardiac disorder—Capecitabine—colon cancer	0.000228	0.00226	CcSEcCtD
Vincristine—ABCB1—epithelium—colon cancer	0.000228	0.0029	CbGeAlD
Vincristine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000227	0.00226	CcSEcCtD
Vincristine—Decreased appetite—Irinotecan—colon cancer	0.000226	0.00225	CcSEcCtD
Vincristine—Insomnia—Fluorouracil—colon cancer	0.000226	0.00224	CcSEcCtD
Vincristine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000225	0.00223	CcSEcCtD
Vincristine—Fatigue—Irinotecan—colon cancer	0.000225	0.00223	CcSEcCtD
Vincristine—Paraesthesia—Fluorouracil—colon cancer	0.000224	0.00223	CcSEcCtD
Vincristine—Constipation—Irinotecan—colon cancer	0.000223	0.00221	CcSEcCtD
Vincristine—Pain—Irinotecan—colon cancer	0.000223	0.00221	CcSEcCtD
Vincristine—Angiopathy—Capecitabine—colon cancer	0.000223	0.00221	CcSEcCtD
Vincristine—Mediastinal disorder—Capecitabine—colon cancer	0.000221	0.0022	CcSEcCtD
Vincristine—Decreased appetite—Fluorouracil—colon cancer	0.000217	0.00215	CcSEcCtD
Vincristine—Alopecia—Capecitabine—colon cancer	0.000217	0.00215	CcSEcCtD
Vincristine—Pancytopenia—Methotrexate—colon cancer	0.000217	0.00215	CcSEcCtD
Vincristine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000215	0.00214	CcSEcCtD
Vincristine—Mental disorder—Capecitabine—colon cancer	0.000215	0.00214	CcSEcCtD
Vincristine—Dysuria—Methotrexate—colon cancer	0.000213	0.00212	CcSEcCtD
Vincristine—Neutropenia—Methotrexate—colon cancer	0.000213	0.00212	CcSEcCtD
Vincristine—Pain—Fluorouracil—colon cancer	0.000213	0.00212	CcSEcCtD
Vincristine—Gastrointestinal pain—Irinotecan—colon cancer	0.000213	0.00212	CcSEcCtD
Vincristine—ABCB1—renal system—colon cancer	0.000211	0.00269	CbGeAlD
Vincristine—Erectile dysfunction—Methotrexate—colon cancer	0.00021	0.00209	CcSEcCtD
Vincristine—Photosensitivity reaction—Methotrexate—colon cancer	0.000208	0.00207	CcSEcCtD
Vincristine—Back pain—Capecitabine—colon cancer	0.000207	0.00205	CcSEcCtD
Vincristine—Abdominal pain—Irinotecan—colon cancer	0.000206	0.00205	CcSEcCtD
Vincristine—Body temperature increased—Irinotecan—colon cancer	0.000206	0.00205	CcSEcCtD
Vincristine—Pneumonia—Methotrexate—colon cancer	0.000205	0.00203	CcSEcCtD
Vincristine—Depression—Methotrexate—colon cancer	0.000203	0.00202	CcSEcCtD
Vincristine—ABCG2—lymph node—colon cancer	0.000201	0.00256	CbGeAlD
Vincristine—Stomatitis—Methotrexate—colon cancer	0.000198	0.00197	CcSEcCtD
Vincristine—Anaemia—Capecitabine—colon cancer	0.000197	0.00196	CcSEcCtD
Vincristine—Body temperature increased—Fluorouracil—colon cancer	0.000197	0.00196	CcSEcCtD
Vincristine—Sweating—Methotrexate—colon cancer	0.000195	0.00194	CcSEcCtD
Vincristine—Vertigo—Capecitabine—colon cancer	0.000192	0.00191	CcSEcCtD
Vincristine—Hypersensitivity—Irinotecan—colon cancer	0.000192	0.00191	CcSEcCtD
Vincristine—Leukopenia—Capecitabine—colon cancer	0.000191	0.0019	CcSEcCtD
Vincristine—Asthenia—Irinotecan—colon cancer	0.000187	0.00186	CcSEcCtD
Vincristine—Hypertension—Capecitabine—colon cancer	0.000184	0.00183	CcSEcCtD
Vincristine—Hypersensitivity—Fluorouracil—colon cancer	0.000184	0.00183	CcSEcCtD
Vincristine—CYP3A4—liver—colon cancer	0.000182	0.00232	CbGeAlD
Vincristine—Myalgia—Capecitabine—colon cancer	0.000182	0.00181	CcSEcCtD
Vincristine—Urinary tract disorder—Methotrexate—colon cancer	0.00018	0.00179	CcSEcCtD
Vincristine—Urethral disorder—Methotrexate—colon cancer	0.000179	0.00178	CcSEcCtD
Vincristine—Diarrhoea—Irinotecan—colon cancer	0.000178	0.00177	CcSEcCtD
Vincristine—ABCB1—lymphoid tissue—colon cancer	0.000175	0.00224	CbGeAlD
Vincristine—Oedema—Capecitabine—colon cancer	0.000174	0.00173	CcSEcCtD
Vincristine—Infection—Capecitabine—colon cancer	0.000173	0.00172	CcSEcCtD
Vincristine—ABCB1—digestive system—colon cancer	0.000173	0.00221	CbGeAlD
Vincristine—Dizziness—Irinotecan—colon cancer	0.000172	0.00171	CcSEcCtD
Vincristine—Nervous system disorder—Capecitabine—colon cancer	0.000171	0.0017	CcSEcCtD
Vincristine—Diarrhoea—Fluorouracil—colon cancer	0.000171	0.0017	CcSEcCtD
Vincristine—Thrombocytopenia—Capecitabine—colon cancer	0.000171	0.0017	CcSEcCtD
Vincristine—Cardiac disorder—Methotrexate—colon cancer	0.00017	0.00168	CcSEcCtD
Vincristine—Hyperhidrosis—Capecitabine—colon cancer	0.000169	0.00167	CcSEcCtD
Vincristine—Anorexia—Capecitabine—colon cancer	0.000166	0.00165	CcSEcCtD
Vincristine—Angiopathy—Methotrexate—colon cancer	0.000166	0.00165	CcSEcCtD
Vincristine—Vomiting—Irinotecan—colon cancer	0.000166	0.00165	CcSEcCtD
Vincristine—Dizziness—Fluorouracil—colon cancer	0.000165	0.00164	CcSEcCtD
Vincristine—Mediastinal disorder—Methotrexate—colon cancer	0.000165	0.00164	CcSEcCtD
Vincristine—Rash—Irinotecan—colon cancer	0.000164	0.00163	CcSEcCtD
Vincristine—Dermatitis—Irinotecan—colon cancer	0.000164	0.00163	CcSEcCtD
Vincristine—Headache—Irinotecan—colon cancer	0.000163	0.00162	CcSEcCtD
Vincristine—Hypotension—Capecitabine—colon cancer	0.000163	0.00162	CcSEcCtD
Vincristine—Alopecia—Methotrexate—colon cancer	0.000161	0.0016	CcSEcCtD
Vincristine—Mental disorder—Methotrexate—colon cancer	0.00016	0.00159	CcSEcCtD
Vincristine—ABCB1—bone marrow—colon cancer	0.00016	0.00204	CbGeAlD
Vincristine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000159	0.00158	CcSEcCtD
Vincristine—Vomiting—Fluorouracil—colon cancer	0.000159	0.00158	CcSEcCtD
Vincristine—Insomnia—Capecitabine—colon cancer	0.000158	0.00157	CcSEcCtD
Vincristine—Rash—Fluorouracil—colon cancer	0.000157	0.00156	CcSEcCtD
Vincristine—Dermatitis—Fluorouracil—colon cancer	0.000157	0.00156	CcSEcCtD
Vincristine—Paraesthesia—Capecitabine—colon cancer	0.000157	0.00156	CcSEcCtD
Vincristine—Headache—Fluorouracil—colon cancer	0.000156	0.00155	CcSEcCtD
Vincristine—Nausea—Irinotecan—colon cancer	0.000155	0.00154	CcSEcCtD
Vincristine—Back pain—Methotrexate—colon cancer	0.000154	0.00153	CcSEcCtD
Vincristine—ABCB1—vagina—colon cancer	0.000153	0.00195	CbGeAlD
Vincristine—Decreased appetite—Capecitabine—colon cancer	0.000152	0.00151	CcSEcCtD
Vincristine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000151	0.0015	CcSEcCtD
Vincristine—Fatigue—Capecitabine—colon cancer	0.00015	0.00149	CcSEcCtD
Vincristine—Constipation—Capecitabine—colon cancer	0.000149	0.00148	CcSEcCtD
Vincristine—Pain—Capecitabine—colon cancer	0.000149	0.00148	CcSEcCtD
Vincristine—Nausea—Fluorouracil—colon cancer	0.000148	0.00147	CcSEcCtD
Vincristine—Anaemia—Methotrexate—colon cancer	0.000147	0.00146	CcSEcCtD
Vincristine—Vertigo—Methotrexate—colon cancer	0.000143	0.00142	CcSEcCtD
Vincristine—Gastrointestinal pain—Capecitabine—colon cancer	0.000143	0.00142	CcSEcCtD
Vincristine—Leukopenia—Methotrexate—colon cancer	0.000142	0.00141	CcSEcCtD
Vincristine—Abdominal pain—Capecitabine—colon cancer	0.000138	0.00137	CcSEcCtD
Vincristine—Body temperature increased—Capecitabine—colon cancer	0.000138	0.00137	CcSEcCtD
Vincristine—Convulsion—Methotrexate—colon cancer	0.000138	0.00137	CcSEcCtD
Vincristine—Myalgia—Methotrexate—colon cancer	0.000135	0.00135	CcSEcCtD
Vincristine—Anaphylactic shock—Methotrexate—colon cancer	0.00013	0.00129	CcSEcCtD
Vincristine—Infection—Methotrexate—colon cancer	0.000129	0.00128	CcSEcCtD
Vincristine—ABCB1—liver—colon cancer	0.000129	0.00165	CbGeAlD
Vincristine—Hypersensitivity—Capecitabine—colon cancer	0.000128	0.00128	CcSEcCtD
Vincristine—Nervous system disorder—Methotrexate—colon cancer	0.000127	0.00126	CcSEcCtD
Vincristine—Thrombocytopenia—Methotrexate—colon cancer	0.000127	0.00126	CcSEcCtD
Vincristine—Hyperhidrosis—Methotrexate—colon cancer	0.000125	0.00125	CcSEcCtD
Vincristine—Asthenia—Capecitabine—colon cancer	0.000125	0.00124	CcSEcCtD
Vincristine—Anorexia—Methotrexate—colon cancer	0.000124	0.00123	CcSEcCtD
Vincristine—Hypotension—Methotrexate—colon cancer	0.000121	0.00121	CcSEcCtD
Vincristine—Diarrhoea—Capecitabine—colon cancer	0.000119	0.00119	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000118	0.00117	CcSEcCtD
Vincristine—Insomnia—Methotrexate—colon cancer	0.000117	0.00117	CcSEcCtD
Vincristine—Paraesthesia—Methotrexate—colon cancer	0.000117	0.00116	CcSEcCtD
Vincristine—Dizziness—Capecitabine—colon cancer	0.000115	0.00115	CcSEcCtD
Vincristine—Decreased appetite—Methotrexate—colon cancer	0.000113	0.00112	CcSEcCtD
Vincristine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000112	0.00111	CcSEcCtD
Vincristine—Fatigue—Methotrexate—colon cancer	0.000112	0.00111	CcSEcCtD
Vincristine—Pain—Methotrexate—colon cancer	0.000111	0.0011	CcSEcCtD
Vincristine—Vomiting—Capecitabine—colon cancer	0.000111	0.0011	CcSEcCtD
Vincristine—Rash—Capecitabine—colon cancer	0.00011	0.00109	CcSEcCtD
Vincristine—Dermatitis—Capecitabine—colon cancer	0.00011	0.00109	CcSEcCtD
Vincristine—Headache—Capecitabine—colon cancer	0.000109	0.00109	CcSEcCtD
Vincristine—Gastrointestinal pain—Methotrexate—colon cancer	0.000106	0.00105	CcSEcCtD
Vincristine—Nausea—Capecitabine—colon cancer	0.000104	0.00103	CcSEcCtD
Vincristine—Body temperature increased—Methotrexate—colon cancer	0.000103	0.00102	CcSEcCtD
Vincristine—Abdominal pain—Methotrexate—colon cancer	0.000103	0.00102	CcSEcCtD
Vincristine—ABCB1—lymph node—colon cancer	9.89e-05	0.00126	CbGeAlD
Vincristine—Hypersensitivity—Methotrexate—colon cancer	9.56e-05	0.00095	CcSEcCtD
Vincristine—Asthenia—Methotrexate—colon cancer	9.31e-05	0.000925	CcSEcCtD
Vincristine—Diarrhoea—Methotrexate—colon cancer	8.88e-05	0.000882	CcSEcCtD
Vincristine—Dizziness—Methotrexate—colon cancer	8.58e-05	0.000853	CcSEcCtD
Vincristine—Vomiting—Methotrexate—colon cancer	8.25e-05	0.00082	CcSEcCtD
Vincristine—Rash—Methotrexate—colon cancer	8.19e-05	0.000813	CcSEcCtD
Vincristine—Dermatitis—Methotrexate—colon cancer	8.18e-05	0.000812	CcSEcCtD
Vincristine—Headache—Methotrexate—colon cancer	8.13e-05	0.000808	CcSEcCtD
Vincristine—Nausea—Methotrexate—colon cancer	7.71e-05	0.000766	CcSEcCtD
Vincristine—SLC22A3—Metabolism—CHST5—colon cancer	7.65e-05	0.00124	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ODC1—colon cancer	7.65e-05	0.00124	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—BUB1B—colon cancer	7.6e-05	0.00123	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—SRC—colon cancer	7.49e-05	0.00121	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—BUB1B—colon cancer	7.43e-05	0.0012	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	7.34e-05	0.00119	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ODC1—colon cancer	7.33e-05	0.00119	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CHST5—colon cancer	7.33e-05	0.00119	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—colon cancer	7.3e-05	0.00118	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	7.09e-05	0.00115	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ODC1—colon cancer	7.03e-05	0.00114	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CHST5—colon cancer	7.03e-05	0.00114	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	6.95e-05	0.00112	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TYMS—colon cancer	6.88e-05	0.00111	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—BUB1B—colon cancer	6.8e-05	0.0011	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—colon cancer	6.7e-05	0.00108	CbGpPWpGaD
Vincristine—ABCC1—Disease—CHST5—colon cancer	6.58e-05	0.00106	CbGpPWpGaD
Vincristine—ABCC1—Disease—LGR5—colon cancer	6.58e-05	0.00106	CbGpPWpGaD
Vincristine—TUBB2B—Transmembrane transport of small molecules—ABCB1—colon cancer	6.48e-05	0.00105	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—ABCB1—colon cancer	6.48e-05	0.00105	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—TYMS—colon cancer	6.37e-05	0.00103	CbGpPWpGaD
Vincristine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.35e-05	0.00103	CbGpPWpGaD
Vincristine—TUBB3—Transmembrane transport of small molecules—ABCB1—colon cancer	6.26e-05	0.00101	CbGpPWpGaD
Vincristine—TUBB2A—Transmembrane transport of small molecules—ABCB1—colon cancer	6.06e-05	0.00098	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	5.97e-05	0.000965	CbGpPWpGaD
Vincristine—TUBB1—Transmembrane transport of small molecules—ABCB1—colon cancer	5.93e-05	0.000958	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—TYMS—colon cancer	5.83e-05	0.000942	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CA7—colon cancer	5.73e-05	0.000927	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	5.7e-05	0.000922	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TYMS—colon cancer	5.7e-05	0.000921	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ODC1—colon cancer	5.51e-05	0.000891	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CHST5—colon cancer	5.51e-05	0.000891	CbGpPWpGaD
Vincristine—TUBB4A—Transmembrane transport of small molecules—ABCB1—colon cancer	5.32e-05	0.00086	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TYMS—colon cancer	5.21e-05	0.000843	CbGpPWpGaD
Vincristine—NR0B1—Generic Transcription Pathway—MYC—colon cancer	5.08e-05	0.000822	CbGpPWpGaD
Vincristine—ABCC3—NRF2 pathway—TGFB1—colon cancer	4.9e-05	0.000793	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—ABCB1—colon cancer	4.87e-05	0.000787	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CHST5—colon cancer	4.85e-05	0.000784	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ODC1—colon cancer	4.85e-05	0.000784	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ODC1—colon cancer	4.81e-05	0.000777	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CHST5—colon cancer	4.81e-05	0.000777	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.77e-05	0.000772	CbGpPWpGaD
Vincristine—ABCC1—Disease—AXIN2—colon cancer	4.73e-05	0.000764	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—AKT1—colon cancer	4.66e-05	0.000753	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CCND1—colon cancer	4.55e-05	0.000736	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	4.43e-05	0.000717	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDKN1A—colon cancer	4.4e-05	0.000712	CbGpPWpGaD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	4.39e-05	0.000709	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CA7—colon cancer	4.33e-05	0.0007	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—ABCB1—colon cancer	4.32e-05	0.000698	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—PPARG—colon cancer	4.29e-05	0.000694	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—EP300—colon cancer	4.19e-05	0.000678	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CCND1—colon cancer	4.07e-05	0.000658	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—EP300—colon cancer	3.97e-05	0.000642	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	3.97e-05	0.000642	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.97e-05	0.000642	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDKN1A—colon cancer	3.94e-05	0.000637	CbGpPWpGaD
Vincristine—ABCC2—NRF2 pathway—TGFB1—colon cancer	3.89e-05	0.000628	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CCND1—colon cancer	3.87e-05	0.000626	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—SRC—colon cancer	3.86e-05	0.000624	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—CASP3—colon cancer	3.83e-05	0.00062	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—VEGFA—colon cancer	3.76e-05	0.000608	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.76e-05	0.000608	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—EP300—colon cancer	3.75e-05	0.000606	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDKN1A—colon cancer	3.75e-05	0.000606	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—NRAS—colon cancer	3.72e-05	0.000601	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.66e-05	0.000592	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MYC—colon cancer	3.65e-05	0.000591	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—EP300—colon cancer	3.56e-05	0.000576	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.52e-05	0.00057	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ODC1—colon cancer	3.47e-05	0.000562	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CHST5—colon cancer	3.47e-05	0.000562	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CCND1—colon cancer	3.46e-05	0.00056	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TGFB1—colon cancer	3.45e-05	0.000558	CbGpPWpGaD
Vincristine—TUBA4A—Metabolism of proteins—CTNNB1—colon cancer	3.36e-05	0.000544	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—FGFR3—colon cancer	3.35e-05	0.000542	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDKN1A—colon cancer	3.35e-05	0.000542	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MYC—colon cancer	3.27e-05	0.000528	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—VEGFA—colon cancer	3.25e-05	0.000526	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CCND1—colon cancer	3.21e-05	0.000519	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—KRAS—colon cancer	3.2e-05	0.000517	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—EP300—colon cancer	3.19e-05	0.000515	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.15e-05	0.000509	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.11e-05	0.000503	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MYC—colon cancer	3.11e-05	0.000502	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDKN1A—colon cancer	3.1e-05	0.000502	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—APC—colon cancer	3.08e-05	0.000497	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.03e-05	0.00049	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.99e-05	0.000483	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—EP300—colon cancer	2.95e-05	0.000478	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—PIK3CA—colon cancer	2.94e-05	0.000475	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CCND1—colon cancer	2.93e-05	0.000475	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.9e-05	0.000469	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—BRAF—colon cancer	2.89e-05	0.000468	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—CTNNB1—colon cancer	2.88e-05	0.000466	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—CTNNB1—colon cancer	2.88e-05	0.000466	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CCND1—colon cancer	2.87e-05	0.000464	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TP53—colon cancer	2.84e-05	0.00046	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDKN1A—colon cancer	2.84e-05	0.000459	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—CTNNB1—colon cancer	2.78e-05	0.00045	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MYC—colon cancer	2.78e-05	0.000449	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDKN1A—colon cancer	2.78e-05	0.000449	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.74e-05	0.000442	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—HRAS—colon cancer	2.72e-05	0.00044	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—EP300—colon cancer	2.7e-05	0.000437	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—CTNNB1—colon cancer	2.7e-05	0.000436	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.68e-05	0.000434	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—colon cancer	2.68e-05	0.000434	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CA7—colon cancer	2.67e-05	0.000431	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—EP300—colon cancer	2.64e-05	0.000427	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—CTNNB1—colon cancer	2.64e-05	0.000426	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND1—colon cancer	2.62e-05	0.000424	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ODC1—colon cancer	2.62e-05	0.000424	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CHST5—colon cancer	2.62e-05	0.000424	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MYC—colon cancer	2.57e-05	0.000416	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDKN1A—colon cancer	2.54e-05	0.00041	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MYC—colon cancer	2.45e-05	0.000396	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—EP300—colon cancer	2.41e-05	0.000391	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—AKT1—colon cancer	2.4e-05	0.000388	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.4e-05	0.000388	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.38e-05	0.000385	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—CTNNB1—colon cancer	2.37e-05	0.000383	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MYC—colon cancer	2.35e-05	0.000381	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MYC—colon cancer	2.3e-05	0.000372	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.28e-05	0.000369	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—colon cancer	2.28e-05	0.000369	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.27e-05	0.000368	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CASP3—colon cancer	2.17e-05	0.000351	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—CTNNB1—colon cancer	2.17e-05	0.00035	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCND1—colon cancer	2.11e-05	0.000341	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MYC—colon cancer	2.1e-05	0.00034	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CTNNB1—colon cancer	2.09e-05	0.000338	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CDKN1A—colon cancer	2.04e-05	0.00033	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.04e-05	0.00033	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ABCB1—colon cancer	2.02e-05	0.000327	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—TYMS—colon cancer	1.99e-05	0.000321	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.98e-05	0.00032	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EP300—colon cancer	1.94e-05	0.000314	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ABCB1—colon cancer	1.94e-05	0.000313	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—TYMS—colon cancer	1.9e-05	0.000308	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.9e-05	0.000307	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.89e-05	0.000306	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—colon cancer	1.89e-05	0.000306	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SRC—colon cancer	1.89e-05	0.000305	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ABCB1—colon cancer	1.86e-05	0.0003	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.84e-05	0.000298	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—VEGFA—colon cancer	1.84e-05	0.000297	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—TYMS—colon cancer	1.82e-05	0.000295	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.82e-05	0.000295	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NRAS—colon cancer	1.82e-05	0.000294	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.79e-05	0.000289	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.78e-05	0.000288	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—colon cancer	1.73e-05	0.000279	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—AKT1—colon cancer	1.7e-05	0.000274	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.7e-05	0.000274	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—colon cancer	1.69e-05	0.000274	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TGFB1—colon cancer	1.69e-05	0.000273	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EGFR—colon cancer	1.66e-05	0.000268	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.65e-05	0.000267	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CHST5—colon cancer	1.61e-05	0.000261	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ODC1—colon cancer	1.61e-05	0.000261	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.61e-05	0.00026	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KRAS—colon cancer	1.56e-05	0.000253	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.49e-05	0.000241	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.48e-05	0.000239	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.47e-05	0.000238	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.47e-05	0.000237	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ABCB1—colon cancer	1.46e-05	0.000235	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.45e-05	0.000234	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PIK3CA—colon cancer	1.44e-05	0.000232	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—TYMS—colon cancer	1.43e-05	0.000231	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PPARG—colon cancer	1.41e-05	0.000227	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.4e-05	0.000227	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—colon cancer	1.39e-05	0.000225	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.37e-05	0.000221	CbGpPWpGaD
Vincristine—ABCC1—Disease—FGFR3—colon cancer	1.36e-05	0.000221	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PPARG—colon cancer	1.35e-05	0.000218	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—colon cancer	1.33e-05	0.000215	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PPARG—colon cancer	1.29e-05	0.000209	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ABCB1—colon cancer	1.28e-05	0.000207	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ABCB1—colon cancer	1.27e-05	0.000205	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—TYMS—colon cancer	1.26e-05	0.000203	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.25e-05	0.000203	CbGpPWpGaD
Vincristine—ABCC1—Disease—APC—colon cancer	1.25e-05	0.000203	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—TYMS—colon cancer	1.25e-05	0.000202	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.21e-05	0.000196	CbGpPWpGaD
Vincristine—ABCC1—Disease—BRAF—colon cancer	1.18e-05	0.00019	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—AKT1—colon cancer	1.17e-05	0.00019	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTGS2—colon cancer	1.11e-05	0.000179	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.1e-05	0.000178	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTGS2—colon cancer	1.06e-05	0.000172	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.02e-05	0.000166	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTGS2—colon cancer	1.02e-05	0.000164	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PPARG—colon cancer	1.01e-05	0.000164	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTGS2—colon cancer	9.51e-06	0.000154	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—EP300—colon cancer	9.2e-06	0.000149	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ABCB1—colon cancer	9.18e-06	0.000148	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—TYMS—colon cancer	9.02e-06	0.000146	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PPARG—colon cancer	8.91e-06	0.000144	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PPARG—colon cancer	8.83e-06	0.000143	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—EP300—colon cancer	8.82e-06	0.000143	CbGpPWpGaD
Vincristine—ABCC1—Disease—CTNNB1—colon cancer	8.51e-06	0.000138	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—EP300—colon cancer	8.46e-06	0.000137	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN1A—colon cancer	8.32e-06	0.000134	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTGS2—colon cancer	7.97e-06	0.000129	CbGpPWpGaD
Vincristine—ABCC1—Disease—EP300—colon cancer	7.91e-06	0.000128	CbGpPWpGaD
Vincristine—ABCC1—Disease—SRC—colon cancer	7.7e-06	0.000124	CbGpPWpGaD
Vincristine—ABCC1—Disease—NRAS—colon cancer	7.4e-06	0.00012	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTGS2—colon cancer	7.01e-06	0.000113	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTGS2—colon cancer	6.95e-06	0.000112	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—colon cancer	6.9e-06	0.000112	CbGpPWpGaD
Vincristine—ABCC1—Disease—TGFB1—colon cancer	6.88e-06	0.000111	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CA—colon cancer	6.81e-06	0.00011	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—TYMS—colon cancer	6.8e-06	0.00011	CbGpPWpGaD
Vincristine—ABCC1—Disease—EGFR—colon cancer	6.74e-06	0.000109	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—EP300—colon cancer	6.63e-06	0.000107	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CA—colon cancer	6.53e-06	0.000106	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPARG—colon cancer	6.39e-06	0.000103	CbGpPWpGaD
Vincristine—ABCC1—Disease—KRAS—colon cancer	6.37e-06	0.000103	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CA—colon cancer	6.26e-06	0.000101	CbGpPWpGaD
Vincristine—ABCC1—Disease—PIK3CA—colon cancer	5.85e-06	9.47e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—EP300—colon cancer	5.83e-06	9.43e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—EP300—colon cancer	5.78e-06	9.35e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AKT1—colon cancer	5.56e-06	8.99e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—colon cancer	5.42e-06	8.76e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AKT1—colon cancer	5.33e-06	8.62e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AKT1—colon cancer	5.11e-06	8.27e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTGS2—colon cancer	5.02e-06	8.12e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CA—colon cancer	4.9e-06	7.93e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPARG—colon cancer	4.82e-06	7.79e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—AKT1—colon cancer	4.78e-06	7.73e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CA—colon cancer	4.31e-06	6.98e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CA—colon cancer	4.28e-06	6.91e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ABCB1—colon cancer	4.27e-06	6.9e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—TYMS—colon cancer	4.19e-06	6.78e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—EP300—colon cancer	4.18e-06	6.76e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AKT1—colon cancer	4e-06	6.48e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTGS2—colon cancer	3.79e-06	6.13e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AKT1—colon cancer	3.52e-06	5.7e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AKT1—colon cancer	3.49e-06	5.65e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—EP300—colon cancer	3.15e-06	5.1e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CA—colon cancer	3.09e-06	5e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPARG—colon cancer	2.97e-06	4.8e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AKT1—colon cancer	2.52e-06	4.08e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTGS2—colon cancer	2.34e-06	3.78e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CA—colon cancer	2.33e-06	3.77e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—EP300—colon cancer	1.94e-06	3.14e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AKT1—colon cancer	1.91e-06	3.08e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.44e-06	2.32e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AKT1—colon cancer	1.17e-06	1.9e-05	CbGpPWpGaD
